Department of Vascular Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, CA, China (mainland).
Department of Vascular Surgery, Tongling People's Hospital, Tongling, Anhui, China (mainland).
Am J Case Rep. 2024 Feb 11;25:e942727. doi: 10.12659/AJCR.942727.
BACKGROUND Managing IgG4-related disease (IgG4-RD) in the context of vascular complications, such as aneurysms, poses significant challenges, particularly when considering surgical intervention options. The risk of rupture and infection in patients on long-term glucocorticoid therapy complicates treatment decisions. CASE REPORT A 63-year-old woman with a history of IgG4-RD presented with a ruptured right iliac artery aneurysm. She was on long-term oral glucocorticoid therapy. Initial emergency endovascular stent graft implantation was followed by embolization for suspected arterial bleeding and subsequent Salmonella bacteremia. Repeated hospitalizations involved stent graft removal and surgical repair due to persistent infection. Over 2 years, the patient required multiple pelvic drainages and long-term antibiotic and prednisolone therapy, yet her quality of life remained compromised. CONCLUSIONS Our case highlights the unique challenges and considerations in the treatment of IgG4-related aneurysms. Patients with IgG4-RD who are on long-term oral glucocorticoids have an inherent risk of aneurysm rupture. We believe regular follow-ups to monitor the progression of the aorta and iliac arteries into aneurysms are essential. For patients who have developed aneurysms, it is advisable to reduce the dosage of glucocorticoids or even consider surgical treatment as soon as possible. As for the choice of surgical method, there is no consensus yet. While endovascular treatment is less invasive and quicker, it can increase the risk of rupture and bleeding. Open surgery might be a better option. More data are needed to make a definitive judgment.
在血管并发症(如动脉瘤)的情况下管理 IgG4 相关疾病(IgG4-RD),尤其是考虑手术干预方案时,存在很大的挑战。长期接受糖皮质激素治疗的患者存在破裂和感染风险,这使治疗决策变得复杂。
一位 63 岁的女性,患有 IgG4-RD,出现右侧髂动脉瘤破裂。她正在接受长期口服糖皮质激素治疗。最初进行了紧急血管内支架移植植入术,随后因疑似动脉出血进行了栓塞,随后出现了沙门氏菌菌血症。由于持续感染,她反复住院进行支架移植取出和手术修复。在 2 年多的时间里,患者需要多次盆腔引流,并长期接受抗生素和泼尼松龙治疗,但生活质量仍然受损。
我们的病例突出了 IgG4 相关动脉瘤治疗的独特挑战和考虑因素。长期接受口服糖皮质激素治疗的 IgG4-RD 患者存在动脉瘤破裂的固有风险。我们认为定期随访以监测主动脉和髂动脉进展为动脉瘤至关重要。对于已经发生动脉瘤的患者,建议减少糖皮质激素的剂量,甚至尽快考虑手术治疗。至于手术方法的选择,目前尚无共识。虽然血管内治疗创伤较小且恢复较快,但会增加破裂和出血的风险。开放性手术可能是更好的选择。需要更多的数据来做出明确的判断。